Ballester, P.; Espadas, C.; Almenara, S.; Barrachina, J.; Muriel, J.; Ramos, E.; Toral, N.; Belda, C.; Peiró, A.M.
CYP2D6 Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder: A Naturalistic Study with Extreme Phenotype Analysis. Pharmaceuticals 2023, 16, 954.
https://doi.org/10.3390/ph16070954
AMA Style
Ballester P, Espadas C, Almenara S, Barrachina J, Muriel J, Ramos E, Toral N, Belda C, Peiró AM.
CYP2D6 Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder: A Naturalistic Study with Extreme Phenotype Analysis. Pharmaceuticals. 2023; 16(7):954.
https://doi.org/10.3390/ph16070954
Chicago/Turabian Style
Ballester, Pura, Cristina Espadas, Susana Almenara, Jordi Barrachina, Javier Muriel, Enrique Ramos, Natalia Toral, César Belda, and Ana M. Peiró.
2023. "CYP2D6 Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder: A Naturalistic Study with Extreme Phenotype Analysis" Pharmaceuticals 16, no. 7: 954.
https://doi.org/10.3390/ph16070954
APA Style
Ballester, P., Espadas, C., Almenara, S., Barrachina, J., Muriel, J., Ramos, E., Toral, N., Belda, C., & Peiró, A. M.
(2023). CYP2D6 Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder: A Naturalistic Study with Extreme Phenotype Analysis. Pharmaceuticals, 16(7), 954.
https://doi.org/10.3390/ph16070954